Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers
Purpose In the past decade, there has been an increase in the development and use of oral
anti-cancer medications (OAMs), especially for breast cancer–the most prevalent cancer in …
anti-cancer medications (OAMs), especially for breast cancer–the most prevalent cancer in …
Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review
Purpose Nonadherence to hormone therapy in breast cancer survivors is common and
associated with increased risk of mortality. Consistent predictors of nonadherence and …
associated with increased risk of mortality. Consistent predictors of nonadherence and …
Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review
Background Adjuvant endocrine therapy (AET) significantly reduces recurrence and
mortality in women with breast cancer (BrCa). Despite the efficacy of AET in improving BrCa …
mortality in women with breast cancer (BrCa). Despite the efficacy of AET in improving BrCa …
Potentially modifiable factors associated with adherence to adjuvant endocrine therapy among breast cancer survivors: a systematic review
Simple Summary Endocrine therapy taken after primary breast cancer treatment helps
prevent breast cancer recurrence. However, many women are unable to adhere to …
prevent breast cancer recurrence. However, many women are unable to adhere to …
Endocrine therapy nonadherence and discontinuation in black and white women
Background Differential use of endocrine therapy (ET) by race may contribute to breast
cancer outcome disparities, but racial differences in ET behaviors are poorly understood …
cancer outcome disparities, but racial differences in ET behaviors are poorly understood …
Factors associated with intentional and unintentional non‐adherence to adjuvant endocrine therapy following breast cancer
Adherence to adjuvant endocrine therapy (AET) following breast cancer is known to be
suboptimal despite its known efficacy in reducing recurrence and mortality. This study aims …
suboptimal despite its known efficacy in reducing recurrence and mortality. This study aims …
Breast cancer patients' experiences of adherence and persistence to oral endocrine therapy: a qualitative evidence synthesis
C Clancy, J Lynch, P OConnor, M Dowling - European Journal of Oncology …, 2020 - Elsevier
Purpose Adjuvant endocrine therapy (AET) significantly reduces the risk of breast cancer
recurrence and mortality in women with hormone receptor (HR+) breast cancer. Despite the …
recurrence and mortality in women with hormone receptor (HR+) breast cancer. Despite the …
A systematic review of interventions to improve adherence to endocrine therapy
Purpose Adherence to endocrine therapy for hormone positive breast cancer is a significant
problem, especially in minority populations. Further, endocrine therapy reduces recurrence …
problem, especially in minority populations. Further, endocrine therapy reduces recurrence …
Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Map** …
Background Adjuvant endocrine therapy (AET) reduces the risk of breast cancer recurrence
and mortality. However, up to three-quarters of women with breast cancer do not take AET …
and mortality. However, up to three-quarters of women with breast cancer do not take AET …
Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL)
DL Hershman, LH Kushi, GC Hillyer… - Breast cancer research …, 2016 - Springer
Non-adherence to adjuvant endocrine therapy (ET) for breast cancer (BC) is common. Our
goal was to determine the associations between psychosocial factors and ET non …
goal was to determine the associations between psychosocial factors and ET non …